More than 9million prescriptions for Ozempic and similar weight loss drugs are written every year in the US, estimates suggest - which is one of the world's fattest nations.
Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate The key to successful biotech investing is straightforward: Own stocks of companies that get drugs approved.
ART27.13 is a highly potent, peripherally restricted new chemical entity, targeting CB 1 and CB 2 receptors ... the CAReS trial as a supportive care therapy for cancer patients suffering from anorexia ...